Corvus Pharmaceuticals, Inc. Capital Expenditures
Corvus Pharmaceuticals, Inc. (CRVS) reported Capital Expenditures of $673.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Corvus Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $582.00K, a 415.04% increase year-over-year.
- Corvus Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $91.00K, a 152.78% increase year-over-year.
- Corvus Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $25.00K.
- Corvus Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
- Corvus Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $174.00K.
- Corvus Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $34.00K, a 87.36% decline from fiscal 2022.
- Corvus Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $269.00K, a 5280.00% increase from fiscal 2021.
- Corvus Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $5.00K, a 93.42% decline from fiscal 2020.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $582.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $673.00K 10-Q · filed 2026-08-06 | $698.00K derived: sum of 3 quarters · filed 2026-08-06 | $698.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $91.00K 10-Q · filed 2026-05-07 | $116.00K derived: sum of 2 quarters · filed 2026-05-07 | $116.00K derived: sum of 3 quarters · filed 2026-05-07 | $229.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $25.00K derived: sum of 2 quarters · filed 2026-03-12 | $138.00K derived: sum of 3 quarters · filed 2026-08-06 | $174.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $113.00K derived: sum of 2 quarters · filed 2026-08-06 | $149.00K 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $149.00K 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $36.00K 10-Q · filed 2026-05-07 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $34.00K 10-K · filed 2026-03-12 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $34.00K 10-Q · filed 2024-11-12 | $34.00K derived: sum of 4 quarters · filed 2025-03-25 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $34.00K 10-Q · filed 2024-08-06 | $34.00K derived: sum of 3 quarters · filed 2025-03-25 | $299.00K derived: sum of 4 quarters · filed 2025-03-25 |
| 2023-03-31 | $34.00K 10-Q · filed 2024-05-07 | $34.00K derived: sum of 2 quarters · filed 2025-03-25 | $299.00K derived: sum of 3 quarters · filed 2025-03-25 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $265.00K derived: sum of 2 quarters · filed 2025-03-25 | $269.00K 10-K · filed 2025-03-25 | |
| 2022-09-30 | $265.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $269.00K 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $4.00K 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $5.00K 10-K · filed 2024-03-19 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $76.00K 10-K · filed 2023-03-28 | ||
| 2020-09-30 | $76.00K 10-Q · filed 2021-11-01 | |||
| 2019-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $9.00K derived: sum of 2 quarters · filed 2022-03-10 | $9.00K derived: sum of 3 quarters · filed 2022-03-10 | $25.00K 10-K · filed 2022-03-10 |
| 2019-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $4.00K derived: sum of 2 quarters · filed 2020-10-29 | $20.00K 10-Q · filed 2020-10-29 | $155.00K derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $16.00K 10-Q · filed 2020-07-30 | $151.00K derived: sum of 3 quarters · filed 2021-03-25 | $311.00K derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-03-31 | $16.00K 10-Q · filed 2020-04-30 | $151.00K derived: sum of 2 quarters · filed 2021-03-25 | $311.00K derived: sum of 3 quarters · filed 2021-03-25 | $365.00K derived: sum of 4 quarters · filed 2021-03-25 |
| 2018-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $295.00K derived: sum of 2 quarters · filed 2021-03-25 | $349.00K derived: sum of 3 quarters · filed 2021-03-25 | $355.00K 10-K · filed 2021-03-25 |
| 2018-09-30 | $160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $214.00K derived: sum of 2 quarters · filed 2019-10-29 | $220.00K 10-Q · filed 2019-10-29 | $212.00K derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $60.00K 10-Q · filed 2019-08-01 | $52.00K derived: sum of 3 quarters · filed 2020-03-09 | $94.00K derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-03-31 | $6.00K 10-Q · filed 2019-05-09 | -$2.00K derived: sum of 2 quarters · filed 2020-03-09 | $40.00K derived: sum of 3 quarters · filed 2020-03-09 | $161.00K derived: sum of 4 quarters · filed 2020-03-09 |
| 2017-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $34.00K derived: sum of 2 quarters · filed 2020-03-09 | $155.00K derived: sum of 3 quarters · filed 2020-03-09 | $266.00K 10-K · filed 2020-03-09 |
| 2017-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $163.00K derived: sum of 2 quarters · filed 2018-11-01 | $274.00K 10-Q · filed 2018-11-01 | $887.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $232.00K 10-Q · filed 2018-08-02 | $845.00K derived: sum of 3 quarters · filed 2019-03-07 | $944.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $111.00K 10-Q · filed 2018-05-03 | $724.00K derived: sum of 2 quarters · filed 2019-03-07 | $823.00K derived: sum of 3 quarters · filed 2019-03-07 | $1.70M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $712.00K derived: sum of 2 quarters · filed 2019-03-07 | $1.58M derived: sum of 3 quarters · filed 2019-03-07 | $2.20M 10-K · filed 2019-03-07 |
| 2016-09-30 | $99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $972.00K derived: sum of 2 quarters · filed 2017-11-02 | $1.59M 10-Q · filed 2017-11-02 | $2.45M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $873.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $1.49M 10-Q · filed 2017-08-03 | $2.35M derived: sum of 3 quarters · filed 2018-03-01 | $2.36M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $614.00K 10-Q · filed 2017-05-04 | $1.48M derived: sum of 2 quarters · filed 2018-03-01 | $1.48M derived: sum of 3 quarters · filed 2018-03-01 | $2.04M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $864.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $870.00K derived: sum of 2 quarters · filed 2018-03-01 | $1.42M derived: sum of 3 quarters · filed 2018-03-01 | $1.75M 10-K · filed 2018-03-01 |
| 2015-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $559.00K derived: sum of 2 quarters · filed 2016-11-03 | $883.00K 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $553.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $877.00K 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $324.00K 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |